JASPER THERAPEUTICS, INC. (JSPR) EBITDA
- 2026-06-30: Basis Reported; EBITDA (m); Operating income -$9.21M; Depreciation and amortization (m).
- 2026-03-31: Basis Reported; EBITDA (m); Operating income -$10.95M; Depreciation and amortization (m).
- 2025-09-30: Basis Reported; EBITDA (m); Operating income -$19.17M; Depreciation and amortization (m).
- 2025-06-30: Basis Reported; EBITDA (m); Operating income -$27.08M; Depreciation and amortization (m).
Complete source-backed ebitda history.
- Available history
- 2022-09-30 to 2023-12-31
- Data captured
Historical EBITDA
EBITDA 3 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2026-06-30 | Reported | (m) | -$9.21M | (m) | (m) | (m) | (m) | -$6.92M* | (m) | $5.13M | (m) | (m) |
|---|
| 2026-03-31 | Reported | (m) | -$10.95M | (m) | (m) | (m) | (m) | -$14.55M | (m) | $5.81M | (m) | (m) |
|---|
| 2025-09-30 | Reported | (m) | -$19.17M | (m) | (m) | (m) | (m) | -$17.00M* | (m) | $14.39M | (m) | (m) |
|---|
| 2025-06-30 | Reported | (m) | -$27.08M | (m) | (m) | (m) | (m) | -$15.45M* | (m) | $21.20M | (m) | (m) |
|---|
| 2025-03-31 | Reported | (m) | -$21.80M | (m) | (m) | (m) | (m) | -$22.84M | (m) | $16.16M | (m) | (m) |
|---|
| 2024-09-30 | Reported | (m) | -$19.89M | (m) | (m) | (m) | (m) | -$14.05M* | (m) | $14.46M | (m) | (m) |
|---|
| 2024-06-30 | Reported | (m) | -$15.99M | (m) | (m) | (m) | (m) | -$11.68M* | (m) | $11.30M | (m) | (m) |
|---|
| 2024-03-31 | Reported | (m) | -$15.07M | (m) | (m) | (m) | (m) | -$15.74M | (m) | $10.30M | (m) | (m) |
|---|
| 2023-12-31 | Reported | -$17.44M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2023-09-30 | Reported | -$19.06M | (m) | (m) | (m) | (m) | (m) | -$11.98M* | (m) | $14.85M | (m) | (m) |
|---|
| 2023-06-30 | Reported | (m) | -$17.83M | (m) | (m) | (m) | (m) | -$13.27M* | (m) | $13.30M | (m) | (m) |
|---|
| 2023-03-31 | Reported | (m) | -$13.95M | (m) | (m) | (m) | (m) | -$10.34M | (m) | $9.80M | (m) | (m) |
|---|
| 2022-12-31 | Reported | -$13.47M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2022-09-30 | Reported | -$12.41M | (m) | (m) | (m) | (m) | (m) | -$9.64M* | (m) | $9.02M | (m) | (m) |
|---|
| 2022-06-30 | Reported | (m) | -$11.96M | (m) | (m) | (m) | (m) | -$9.36M* | (m) | $8.13M | (m) | (m) |
|---|
| 2022-03-31 | Reported | (m) | -$12.78M | (m) | (m) | (m) | (m) | -$14.21M | (m) | $8.19M | (m) | (m) |
|---|
| 2021-09-30 | Reported | (m) | -$10.08M | (m) | (m) | (m) | (m) | -$7.11M* | (m) | $7.19M | (m) | (m) |
|---|
| 2021-06-30 | Reported | (m) | -$8.42M | (m) | (m) | (m) | (m) | -$5.79M* | (m) | $5.16M | (m) | (m) |
|---|
| 2021-03-31 | Reported | (m) | -$6.25M | (m) | (m) | (m) | (m) | -$6.20M | (m) | $4.42M | (m) | (m) |
|---|
| 2020-09-30 | Reported | (m) | -$6.01M | (m) | (m) | (m) | (m) | -$12.47M* | (m) | $4.52M | (m) | -$8.21K |
|---|
| 2020-06-30 | Reported | (m) | -$327.56K | (m) | (m) | (m) | (m) | -$173.85K* | (m) | (m) | (m) | -$1.20K |
|---|
| 2020-03-31 | Reported | (m) | -$228.67K | (m) | (m) | (m) | (m) | -$232.87K | (m) | (m) | (m) | $57.82K |
|---|
EBITDA 12 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2025-12-31 | Reported | (m) | -$83.88M | (m) | (m) | (m) | (m) | -$77.16M | (m) | $63.10M | (m) | (m) |
|---|
| 2024-12-31 | Reported | (m) | -$76.24M | (m) | (m) | (m) | (m) | -$62.60M | (m) | $55.82M | (m) | $2.00K |
|---|
| 2023-12-31 | Reported | -$67.75M | (m) | (m) | (m) | (m) | (m) | -$52.07M | (m) | $51.78M | (m) | $2.00K |
|---|
| 2022-12-31 | Reported | -$50.22M | (m) | (m) | (m) | (m) | (m) | -$45.86M | (m) | $34.63M | (m) | (m) |
|---|
| 2021-12-31 | Reported | (m) | -$36.83M | (m) | (m) | (m) | (m) | -$33.68M | (m) | $25.42M | (m) | (m) |
|---|
| 2020-12-31 | Reported | (m) | -$20.68M | (m) | (m) | (m) | (m) | -$18.27M | (m) | $15.88M | (m) | $38.45K |
|---|